Minglong Chen
Impact in
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Pharmaceutical Science top 0.2%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Cardiac Arrhythmias and Treatments 101
- Atrial Fibrillation Management and Outcomes 92
- Cardiac electrophysiology and arrhythmias 26
- Cardiac pacing and defibrillation studies 14
-
- Advancements in Transdermal Drug Delivery 16
- Co-authors
- Chuanbin Wu (27 shared papers)Xiaojun Wu (8 shared papers)Xin Pan (23 shared papers)Guilan Quan (22 shared papers)Kejiang Cao (56 shared papers)Fengxiang Zhang (69 shared papers)Bing Yang (61 shared papers)Hongwu Chen (99 shared papers)
- Journals
- Heart Rhythm (20 papers)Pacing and Clinical Electrophysiology (19 papers)Journal of Interventional Cardiac Electrophysiology (18 papers)Circulation Arrhythmia and Electrophysiology (17 papers)Journal of Cardiovascular Electrophysiology (13 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Minglong Chen
328 papers receiving 9.4k citations
Minglong Chen's Hit Papers
Peers
Comparison fields: 5 of 160
- Cardiology and Cardiovascular Medicine 4.4k
- Pharmaceutical Science 914
- Renewable Energy, Sustainability and the Environment 940
- Pollution 337
- Biomaterials 227
Countries citing papers authored by Minglong Chen
This map shows the geographic impact of Minglong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglong Chen more than expected).
Fields of papers citing papers by Minglong Chen
This network shows the impact of papers produced by Minglong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglong Chen. The network helps show where Minglong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minglong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 358 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Complete Isolation of Left Atrium Surrounding the Pulmonary Veins Hit paper breakdown → | 2004 | 617 |
| 2 | 2019 | 454 | |
| 3 | 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation Hit paper breakdown → | 2024 | 378 |
| 4 | 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias Hit paper breakdown → | 2019 | 353 |
| 5 | 2018 | 344 | |
| 6 | 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias Hit paper breakdown → | 2019 | 294 |
| 7 | 2018 | 247 | |
| 8 | 2020 | 221 | |
| 9 | 2017 | 171 | |
| 10 | 2018 | 166 | |
| 11 | 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation Hit paper breakdown → | 2024 | 165 |
| 12 | 2015 | 144 | |
| 13 | 2016 | 138 | |
| 14 | 2017 | 138 | |
| 15 | 2021 | 133 | |
| 16 | 2020 | 116 | |
| 17 | 2019 | 112 | |
| 18 | 2020 | 108 | |
| 19 | Piezo1‐mediated M2 macrophage mechanotransduction enhances bone formation through secretion and activation of transforming growth factor‐β1 Hit paper breakdown → | 2023 | 104 |
| 20 | 2022 | 100 |
About Minglong Chen
Minglong Chen is a scholar working on Cardiology and Cardiovascular Medicine, Pharmaceutical Science, Biomaterials, Biomedical Engineering and Genetics, having authored 358 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (101 papers), Atrial Fibrillation Management and Outcomes (92 papers), Cardiac electrophysiology and arrhythmias (26 papers), Nanoplatforms for cancer theranostics (19 papers), Advancements in Transdermal Drug Delivery (16 papers), Cardiac pacing and defibrillation studies (14 papers), Nanoparticle-Based Drug Delivery (12 papers) and Pluripotent Stem Cells Research (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.4k citations), Pharmaceutical Science (914 citations), Renewable Energy, Sustainability and the Environment (940 citations), Pollution (337 citations) and Biomaterials (227 citations). Minglong Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Chuanbin Wu, Xiaojun Wu, Xin Pan, Guilan Quan, Kejiang Cao, Fengxiang Zhang, Bing Yang, Hongwu Chen, Ying Hao Sun and Weizhu Ju. Their work appears in journals such as Heart Rhythm, Pacing and Clinical Electrophysiology, Journal of Interventional Cardiac Electrophysiology, Circulation Arrhythmia and Electrophysiology and Journal of Cardiovascular Electrophysiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.